close
MENU
Tech & Innovation
3 mins to read

Kiwi medical device company Chitogel secures US$6.6m investment

The investment by US-based McGeever comes before an $8m Series A funding round.

The patented gel has been sold in the US since 2019.

Wellington-based medical device company Chitogel has scored US$6.58 million ($10.7m) in investment over three years from United States investor McGeever ahead of an $8m Series A capital raise.

Chitogel sells a wound-healing gel, used post-operatively in endoscopic sinus surgery, mainly based on

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Fiona Rotherham Mon, 07 Oct 2024
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Kiwi medical device company Chitogel secures US$6.6m investment
Tech & Innovation,
106168
true